1310685-40-5 Usage
Uses
Used in Cancer Treatment:
D-750901 is used as a targeted therapy for cancer treatment, specifically for cancer cells with a particular mutation. It works by inhibiting the growth and proliferation of these cancer cells by targeting specific pathways and signaling mechanisms involved in cancer progression.
Used in Pharmaceutical Research:
D-750901 is used in pharmaceutical research for the development of new cancer treatments. Its potential as a tyrosine kinase inhibitor and its ability to target specific cancer cells make it a promising candidate for further investigation and development.
Used in Preclinical Studies:
D-750901 is used in preclinical studies to evaluate its efficacy and safety as a potential cancer treatment. These studies help to determine the specific mechanisms of action and potential side effects of D-750901, providing valuable information for its further development and potential clinical use.
Check Digit Verification of cas no
The CAS Registry Mumber 1310685-40-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,0,6,8 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1310685-40:
(9*1)+(8*3)+(7*1)+(6*0)+(5*6)+(4*8)+(3*5)+(2*4)+(1*0)=125
125 % 10 = 5
So 1310685-40-5 is a valid CAS Registry Number.
1310685-40-5Relevant academic research and scientific papers
PIPERAZINYLPYRIMIDINE ANALOGUES AS PROTEIN KINASE INHIBITORS
-
Page/Page column 16, (2012/03/12)
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as protein kinase inhibitors. The compounds may be useful in treating or preventing different cellular proliferation disorders, such as cancer. The present invent
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives
Shallal, Hassan M.,Russu, Wade A.
supporting information; experimental part, p. 2043 - 2057 (2011/06/21)
Protein kinases play several pertinent roles in cell proliferation, and targeting these proteins has been shown to be a successful strategy toward controlling different malignancies. Despite the great discovery stories during the last two decades, there i
